ALEXANDRIA, Va., July 30 -- United States Patent no. 12,372,524, issued on July 29, was assigned to The Johns Hopkins University (Baltimore).

"Anti-PAD2 antibody for treating and evaluating autoimmune and inflammatory diseases" was invented by Erika L. Darrah (Baltimore) and Felipe Andrade (Timonium, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for measuring anti-PAD2 antibodies in a subject with an inflammatory or autoimmune disease, and to determine if the subject has a better prognosis for developing a more severe form of inflammation based on anti-PAD2 antibody levels. Methods for the therapeutic use of anti-PAD2 antibodies are also described."

The patent was filed on Feb. 17, 2023, under...